Trial Profile
Comparison of sitafloxacin-based regimens as third-line therapy in patients with H. pylori infections
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Sep 2015
Price :
$35
*
At a glance
- Drugs Sitafloxacin (Primary) ; Amoxicillin; Metronidazole; Rabeprazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 03 Jan 2014 New trial record
- 13 Nov 2013 Results published in the Journal of Gastroenterology and Hepatology.